A_DT
negative_JJ
role_NN
for_IN
phosphoinositide_NN
3-kinase_NN
in_IN
T-cell_NN
antigen_NN
receptor_NN
function_NN
._.

BACKGROUND_NN
:_:
A_DT
delicate_JJ
balance_NN
between_IN
positive_JJ
and_CC
negative_JJ
regulatory_JJ
mechanisms_NNS
during_IN
T-cell_NN
activation_NN
determines_VBZ
the_DT
specificity_NN
and_CC
magnitude_NN
of_IN
an_DT
immune_JJ
response_NN
._.

Phosphoinositide_NN
3-kinase_NN
-LRB-_-LRB-
PI_NN
3-kinase_NN
-RRB-_-RRB-
is_VBZ
activated_VBN
by_IN
a_DT
diverse_JJ
set_NN
of_IN
receptors_NNS
that_WDT
determine_VBP
T-cell_NN
function_NN
,_,
including_VBG
the_DT
T-cell_NN
antigen_NN
receptor_NN
-LRB-_-LRB-
TCR_NN
-RRB-_-RRB-
,_,
the_DT
costimulatory_JJ
receptor_NN
CD28_NN
,_,
and_CC
negative_JJ
regulators_NNS
of_IN
T-cell_NN
activation_NN
such_JJ
as_IN
CTLA-4_NN
._.

PI_NN
3-kinase_NN
is_VBZ
also_RB
regulated_VBN
by_IN
the_DT
hematopoietic_JJ
cytokines_NNS
that_WDT
determine_VBP
T-cell_NN
differentiation_NN
and_CC
lymphocyte_NN
proliferation_NN
._.

PI_NN
3-kinase_NN
can_MD
thus_RB
dynamically_RB
influence_VB
the_DT
outcome_NN
of_IN
the_DT
immune_JJ
reactions_NNS
at_IN
various_JJ
stages_NNS
._.

In_IN
this_DT
study_NN
,_,
we_PRP
investigated_VBD
the_DT
importance_NN
of_IN
PI_NN
3-kinase_NN
in_IN
TCR-directed_JJ
T-cell_NN
activation_NN
using_VBG
activated_JJ
or_CC
inhibitory_JJ
versions_NNS
of_IN
PI_NN
3-kinase_NN
._.

RESULTS_NNS
:_:
Certain_JJ
aspects_NNS
of_IN
TCR_NN
responses_NNS
such_JJ
as_IN
the_DT
induction_NN
of_IN
transcriptional_JJ
activity_NN
of_IN
AP1_NN
and_CC
serum_NN
response_NN
factor_NN
were_VBD
not_RB
affected_VBN
by_IN
expression_NN
of_IN
the_DT
mutant_JJ
forms_NNS
of_IN
PI_NN
3-kinase_NN
._.

We_PRP
found_VBD
,_,
however_RB
,_,
that_IN
PI_NN
3-kinase_NN
profoundly_RB
influenced_VBD
the_DT
transactivation_NN
capacity_NN
of_IN
'_``
nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
'_''
-LRB-_-LRB-
NF-AT_NN
-RRB-_-RRB-
elicited_VBN
by_IN
the_DT
TCR_NN
:_:
expression_NN
of_IN
an_DT
activated_VBN
form_NN
of_IN
PI_NN
3-kinase_NN
inhibited_VBD
TCR-mediated_JJ
NF-AT_NN
responses_NNS
,_,
whereas_IN
expression_NN
of_IN
a_DT
dominant_JJ
negative_JJ
mutant_NN
of_IN
PI_NN
3-kinase_NN
potently_RB
enhanced_VBD
TCR-controlled_JJ
NF-AT_NN
induction_NN
._.

These_DT
effects_NNS
of_IN
PI_NN
3-kinase_NN
were_VBD
not_RB
mediated_VBN
by_IN
previously_RB
identified_VBN
PI_NN
3-kinase_NN
effectors_NNS
,_,
such_JJ
as_IN
protein_NN
kinase_NN
B_NN
,_,
a_DT
positive_JJ
regulator_NN
of_IN
PI_NN
3-kinase_NN
,_,
or_CC
the_DT
GTPase_NN
Rac_NN
,_,
and_CC
are_VBP
therefore_RB
likely_JJ
to_TO
involve_VB
a_DT
novel_JJ
,_,
as_IN
yet_RB
unknown_JJ
,_,
effector_NN
molecule_NN
._.

CONCLUSIONS_NNS
:_:
Our_PRP$
results_NNS
establish_VBP
that_IN
PI_NN
3-kinase_NN
can_MD
both_CC
positively_RB
and_CC
negatively_RB
regulate_VB
T-cell_NN
function_NN
,_,
and_CC
uncover_VB
a_DT
previously_RB
unrecognized_JJ
function_NN
for_IN
PI_NN
3-kinase_NN
in_IN
T_NN
cells_NNS
as_IN
a_DT
selective_JJ
negative_JJ
regulator_NN
of_IN
TCR-signalling_JJ
events_NNS
and_CC
therefore_RB
as_IN
a_DT
determinant_NN
of_IN
T-cell_NN
homeostasis_NN
._.

